Hepatocellular MR contrast agents: Enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine
- 1 September 2012
- journal article
- research article
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (9) , 2037-2041
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Gadoxetate Disodium–Enhanced MRI of the Liver: Part 1, Protocol Optimization and Lesion Appearance in the Noncirrhotic LiverAmerican Journal of Roentgenology, 2010
- Contrast agents for hepatic MRICancer Imaging, 2007
- Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field StrengthsInvestigative Radiology, 2005
- Congenital and Acquired Anomalies of the Portal Venous SystemRadioGraphics, 2002
- Absence of Bifurcation of the Portal VeinRadiology, 1999
- Gadobenate dimeglumine (BOPTA) enhanced MR imaging: Patterns of enhancement in normal liver and cirrhosisJournal of Magnetic Resonance Imaging, 1998
- Portal vein anomaly associated with deviation of the ligamentum teres to the right and malposition of the gallbladder.Radiology, 1998
- Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.Radiology, 1996
- Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.Radiology, 1996
- New directions in the development of MR imaging contrast media.Radiology, 1992